HomeBusinessHealthcareOverlooked Stocks: ADGI, NRXP, SGRY
Overlooked Stocks: ADGI, NRXP, SGRY

Adagio Therapeutics (ADGI) stock price was up around 86% today. The clinical-stage biopharmaceutical company focuses on antibody-based solutions for infectious diseases. Currently, it is developing "ADG20" for the treatment and prevention of Covid-19. NRX Pharmaceuticals (NRXP) stock price was up 20% today. The clinical-stage small molecule pharmaceutical company stock spiked today following news of its ZYESAMI Covid-19 treatment. Finally, George Tsilis discusses Surgery Partners (SGRY) as the stock was upgraded to buy from hold at Stifel with a $51 price target.

Market On Close

29 Nov 2021

ON AIR
2:00 pm
Market On Close
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
ON AIR
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US